What is Valproate?
Valproate is an anticonvulsant medication that belongs to a class of drugs called antiepileptic drugs (AEDs). It is primarily used to treat epilepsy, bipolar disorder, and prevent migraine headaches. Valproate has been widely prescribed since the 1970s and is considered one of the most effective broad-spectrum antiepileptic medications available.
Uses
Valproate is approved for several medical conditions:
Epilepsy: Used to control various types of seizures, including absence seizures, tonic-clonic seizures, and complex partial seizures. It is particularly effective for generalized epilepsy syndromes.
Bipolar disorder: Helps stabilize mood and prevent manic episodes in adults with bipolar I disorder. It can be used alone or in combination with other mood stabilizers.
Migraine prevention: Reduces the frequency and severity of migraine headaches when taken regularly as a preventive treatment.
Acute mania: Used to treat manic or mixed episodes associated with bipolar disorder, helping to control symptoms like elevated mood, racing thoughts, and impulsive behavior.
Off-label uses: Sometimes prescribed for certain psychiatric conditions, neuropathic pain, and other seizure-related disorders under medical supervision.
How it works
Valproate works by affecting neurotransmitter activity in the brain through multiple mechanisms. It increases levels of gamma-aminobutyric acid (GABA), a calming neurotransmitter, while also blocking sodium and calcium channels in nerve cells. These actions help stabilize electrical activity in the brain, preventing seizures and mood episodes.
Side effects
Common side effects:
- Nausea and vomiting
- Drowsiness or fatigue
- Dizziness
- Weight gain
- Hair loss or changes in hair texture
- Tremor
- Diarrhea
- Abdominal pain
Serious side effects requiring immediate medical attention:
- Severe liver damage (hepatotoxicity)
- Pancreatitis (inflammation of the pancreas)
- Severe allergic reactions or skin rash
- Blood disorders (low platelet count, bleeding)
- Suicidal thoughts or behavior
Warnings and precautions
Pregnancy risk: Valproate carries significant risks during pregnancy, including birth defects and developmental delays. Women of childbearing age should use effective contraception and discuss family planning with their healthcare provider.
Liver function: Regular liver function tests are required, especially during the first six months of treatment, as valproate can cause serious liver damage, particularly in children under two years old.
Blood monitoring: Periodic blood tests are necessary to monitor for blood disorders, including low platelet counts that can increase bleeding risk.
Suicidal ideation: Like other antiepileptic drugs, valproate may increase the risk of suicidal thoughts and behaviors, requiring careful monitoring of mood changes.
Age considerations: Children and elderly patients may be at higher risk for certain side effects and require more frequent monitoring and dose adjustments.
Interactions
Valproate has numerous significant drug interactions:
Warfarin: Valproate can increase bleeding risk by displacing warfarin from protein binding sites and affecting platelet function.
Lamotrigine: Valproate significantly increases lamotrigine levels, requiring substantial dose reductions of lamotrigine to prevent serious skin reactions.
Phenytoin: Complex interaction where valproate can increase free phenytoin levels while total levels may appear normal or decreased.
Carbamazepine: Mutual interaction where both drugs can affect each other’s metabolism, requiring careful dose monitoring.
Topiramate: Increased risk of hyperammonemia and encephalopathy when used together.
Aspirin: Can increase valproate levels by displacing it from protein binding sites, potentially leading to toxicity.
Carbapenem antibiotics: Can dramatically reduce valproate levels, potentially leading to breakthrough seizures.
Alcohol: Increases central nervous system depression and may affect liver metabolism.
Check interactions with the GMJ Interaction Checker
Dosage
Dosage varies significantly based on the condition being treated and individual patient factors. For epilepsy, adults typically start with 10-15 mg per kilogram of body weight daily, divided into two or three doses, with gradual increases as needed. For bipolar disorder, initial doses usually range from 750-1000 mg daily in divided doses. For migraine prevention, doses typically range from 250-1000 mg daily. Blood level monitoring is often used to optimize dosing, with therapeutic levels generally between 50-100 mcg/mL. All dosage decisions should be made by a healthcare provider based on individual patient needs, response to treatment, and blood level monitoring.
Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.
Cite this page
GMJ News Desk. "Valproate." GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/drug/valproate/
This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).Was this article helpful?


